journal
Journals Journal of Endocrinological In...

Journal of Endocrinological Investigation

https://read.qxmd.com/read/38647948/preconceptional-maternal-hyperandrogenism-and-metabolic-syndrome-risk-in-male-offspring-a-long-term-population-based-study
#1
JOURNAL ARTICLE
M Noroozzadeh, M Rahmati, M Amiri, M Saei Ghare Naz, F Azizi, F Ramezani Tehrani
PURPOSE: There is limited research on the effects of maternal hyperandrogenism (MHA) on cardiometabolic risk factors in male offspring. We aimed to compare the risk of metabolic syndrome (MetS) in sons of women with preconceptional hyperandrogenism (HA) to those of non-HA women in later life. METHODS: Using data obtained from the Tehran Lipid and Glucose Cohort Study, with an average of 20 years follow-up, 1913 sons were divided into two groups based on their MHA status, sons with MHA (n = 523) and sons without MHA (controls n = 1390)...
April 22, 2024: Journal of Endocrinological Investigation
https://read.qxmd.com/read/38644453/efficacy-of-topical-minoxidil-in-enhancing-beard-growth-in-a-group-of-transgender-assigned-female-at-birth-individuals-on-gender-affirming-hormone-therapy
#2
JOURNAL ARTICLE
L Marinelli, A Bichiri, S Cagnina, L Castella, E Ghigo, G Motta
PURPOSE: Testosterone therapy represents the cornerstone of gender affirming hormone therapy (GAHT) among t-AFAB (transgender Assigned Female At Birth) people. Minoxidil is a vasodilator drug approved for topical use for the treatment of androgenetic alopecia. The aim of the present study was to evaluate the efficacy of topical minoxidil in enhancing beard growth in a group of t-AFAB people on GAHT. METHODS: Sixteen t-AFAB individuals with an incomplete beard development, on GAHT for at least 6 months, were enrolled...
April 21, 2024: Journal of Endocrinological Investigation
https://read.qxmd.com/read/38643322/sarcopenic-obesity-and-reduced-bmd-in-young-men-living-with-hiv-body-composition-and-sex-steroids-interplay
#3
JOURNAL ARTICLE
S De Vincentis, C Greco, F Fanelli, M C Decaroli, C Diazzi, M Mezzullo, J Milic, M C De Santis, L Roli, U Pagotto, G Guaraldi, V Rochira
PURPOSE: Sex steroids play a key role on male bone homeostasis and body composition (BC), their role in men living with HIV (MLWH) is less recognized. This study aimed at investigating the prevalence of low BMD, sarcopenia, and sarcopenic obesity (SO) and their relationship with sex steroids in MLWH aged < 50. METHODS: Prospective, cross-sectional, observational study on MLWH younger than 50 (median age 47.0 years). BC and BMD were evaluated with DXA...
April 20, 2024: Journal of Endocrinological Investigation
https://read.qxmd.com/read/38642306/cd20%C3%A2-%C3%A2-t-lymphocytes-in-isolated-hashimoto-s-thyroiditis-and-type-3-autoimmune-polyendocrine-syndrome-a-pilot-study
#4
JOURNAL ARTICLE
Ilaria Stramazzo, Giorgio Mangino, Silvia Capriello, Giovanna Romeo, Silvia Martina Ferrari, Poupak Fallahi, Maria Flavia Bagaglini, Marco Centanni, Camilla Virili
BACKGROUND: CD20+ T cells represent up to 5% of circulating T lymphocytes. These cells have been shown to produce higher levels of IL-17A and IFN-γ than those of CD20-  T lymphocytes. Some reports described the role of CD20+ T cells in autoimmune disorders such as multiple sclerosis and rheumatoid arthritis possibly due to their ability to produce these inflammatory cytokines. This study is aimed at describing the behavior of CD20+ T lymphocytes in the most frequent autoimmune disorder, i...
April 20, 2024: Journal of Endocrinological Investigation
https://read.qxmd.com/read/38637430/endocrine-disruptors-aryl-hydrocarbon-receptor-and-cortisol-secretion
#5
REVIEW
F Pecori Giraldi, F Ferraù, M Ragonese, S Cannavò
PURPOSE: Endocrine disruptors exert a plethora of effects in endocrine tissues, from altered function to carcinogenesis. Given its lipophilic nature, the adrenal cortex represents an ideal target for endocrine disruptors and thus, possibly, xenobiotic-induced adrenocortical dysfunction. However, there is no clear understanding of the effect of endocrine disruptors on adrenal steroidogenesis, in particular as regards the aryl hydrocarbon receptor (AHR) pathway, one of the key mediators...
April 18, 2024: Journal of Endocrinological Investigation
https://read.qxmd.com/read/38635114/familial-states-of-primary-hyperparathyroidism-an-update
#6
REVIEW
F Cetani, E Dinoi, L Pierotti, E Pardi
BACKGROUND: Familial primary hyperparathyroidism (PHPT) includes syndromic and non-syndromic disorders. The former are characterized by the occurrence of PHPT in association with extra-parathyroid manifestations and includes multiple endocrine neoplasia (MEN) types 1, 2, and 4 syndromes, and hyperparathyroidism-jaw tumor (HPT-JT). The latter consists of familial hypocalciuric hypercalcemia (FHH) types 1, 2 and 3, neonatal severe primary hyperparathyroidism (NSHPT), and familial isolated primary hyperparathyroidism (FIHP)...
April 18, 2024: Journal of Endocrinological Investigation
https://read.qxmd.com/read/38630213/italian-guidelines-for-the-management-of-adult-individuals-with-overweight-and-obesity-and-metabolic-comorbidities-that-are-resistant-to-behavioral-treatment
#7
JOURNAL ARTICLE
M Chianelli, L Busetto, R Vettor, B Annibale, A Paoletta, E Papini, A Albanese, M Carabotti, D Casarotto, G De Pergola, O E Disoteo, I Grandone, G Medea, E Nisoli, M Raffaelli, S Schiff, F Vignati, M Cinquini, M Gonzalez-Lorenzo, V A Fittipaldo, S Minozzi, M Monteforte, A C Tralongo, R Novizio, A Persichetti, I Samperi, A Scoppola, G Borretta, M Carruba, M G Carbonelli, M De Luca, S Frontoni, S G Corradini, F Muratori, R Attanasio
AIM: This guideline (GL) is aimed at providing a clinical practice reference for the management of adult patients with overweight or obesity associated with metabolic complications who are resistant to lifestyle modification. METHODS: Surgeons, endocrinologists, gastroenterologists, psychologists, pharmacologists, a general practitioner, a nutritionist, a nurse and a patients' representative acted as multi-disciplinary panel. This GL has been developed following the Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach...
April 17, 2024: Journal of Endocrinological Investigation
https://read.qxmd.com/read/38627331/brain-morphometry-and-estimation-of-aging-brain-in-subjects-with-congenital-untreated-isolated-gh-deficiency
#8
JOURNAL ARTICLE
Keila R Villar-Gouy, Carlos Ernesto Garrido Salmon, Roberto Salvatori, Michael Kellner, Miriam P O Krauss, Tâmara O Rocha, Erick Almeida de Souza, Vanderlan O Batista, Ângela C Leal, Lucas B Santos, Enaldo V Melo, Alécia A Oliveira-Santos, Carla R P Oliveira, Viviane C Campos, Elenilde G Santos, Nathalie O Santana, Francisco A Pereira, Rivia S Amorim, José Donato-Junior, José Augusto Soares Barreto Filho, Antonio Carlos Santos, Manuel H Aguiar-Oliveira
PURPOSE: Individuals with isolated GH deficiency (IGHD) due to a mutation in the GHRH receptor gene have a normal life expectancy and above 50 years of age, similar total cognitive performance, with better attention and executive function than controls. Our objectives were to evaluate their brain morphometry and brain aging using MRI. METHODS: Thirteen IGHD and 14 controls matched by age, sex, and education, were enrolled. Quantitative volumetric data and cortical thickness were obtained by automatic segmentation using Freesurfer software...
April 16, 2024: Journal of Endocrinological Investigation
https://read.qxmd.com/read/38619729/an-objective-way-to-predict-remission-and-relapse-in-cushing-disease-using-bayes-theorem-of-probability
#9
JOURNAL ARTICLE
N Gupta, B D Konsam, R Walia, S K Bhadada, R Chhabra, S Dhandapani, A Singh, C K Ahuja, N Sachdeva, U N Saikia
OBJECTIVE: In this study on patients with Cushing disease, post-transsphenoidal surgery (TSS), we attempt to predict the probability of remaining in remission, at least for a year and relapse after that, using Bayes' theorem and the equation of conditional probability. The number of parameters, as well as the weightage of each, is incorporated in this equation. DESIGN AND METHODS: The study design was a single-centre ambispective study. Ten clinical, biochemical, radiological and histopathological parameters capable of predicting Cushing disease remission were identified...
April 15, 2024: Journal of Endocrinological Investigation
https://read.qxmd.com/read/38605186/the-impact-of-overweight-on-lipid-phenotype-in-different-forms-of-dyslipidemia-a-retrospective-cohort-study
#10
JOURNAL ARTICLE
E Formisano, E Proietti, C Borgarelli, S G Sukkar, M Albertelli, M Boschetti, L Pisciotta
PURPOSE: Dyslipidemia plays a pivotal role in increasing cardiovascular risk. In clinical practice the misleading association between altered lipid profile and obesity is common, therefore genetically inherited dyslipidemias may not completely be addressed among patients with overweight. Thus, we aim to investigate the influence of overweight and obesity on the lipid phenotype in a cohort of patients with different forms of dyslipidemia. METHODS: A retrospective analysis was conducted on patients with dyslipidemia from 2015 to 2022...
April 11, 2024: Journal of Endocrinological Investigation
https://read.qxmd.com/read/38602658/simplified-integration-of-optimal-self-management-behaviors-is-associated-with-improved-hba1c-in-patients-with-type-1-diabetes
#11
JOURNAL ARTICLE
C Deng, Y Xie, F Liu, X Tang, L Fan, X Yang, Y Chen, Z Zhou, X Li
PURPOSE: Living with type 1 diabetes requires burdensome and complex daily diabetes self-management behaviors. This study aimed to determine the association between integrated behavior performance and HbA1c, while identifying the behavior with the most significant impact on HbA1c. METHODS: A simple and feasible questionnaire was used to collect diabetes self-management behavior in patients with type 1 diabetes (n = 904). We assessed six dimensions of behavior performance: continuous glucose monitor (CGM) usage, frequent glucose testing, insulin pump usage, carbohydrate counting application, adjustment of insulin doses, and usage of apps for diabetes management...
April 11, 2024: Journal of Endocrinological Investigation
https://read.qxmd.com/read/38578580/clinico-pathological-factors-associated-with-radioiodine-refractory-differentiated-thyroid-carcinoma-status
#12
JOURNAL ARTICLE
L Schubert, A M Mbekwe-Yepnang, J Wassermann, Y Braik-Djellas, L Jaffrelot, F Pani, G Deniziaut, C Lussey-Lepoutre, N Chereau, L Leenhardt, M- O Bernier, C Buffet
PURPOSE: Risk factors for developing radioiodine refractory thyroid cancer (RAIR-TC) have rarely been analyzed. The purpose of the present study was to find clinical and pathological features associated with the occurrence of RAIR-disease in differentiated thyroid cancers (DTC) and to establish an effective predictive risk score. METHODS: All cases of RAIR-DTC treated in our center from 1990 to 2020 were retrospectively reviewed. Each case was matched randomly with at least four RAI-avid DTC control patients based on histological and clinical criteria...
April 5, 2024: Journal of Endocrinological Investigation
https://read.qxmd.com/read/38568373/asprosin-its-function-as-a-novel-endocrine-factor-in-metabolic-related-diseases
#13
REVIEW
Y Zhang, P Yang, X Zhang, S Liu, K Lou
BACKGROUND AND PURPOSE: Asprosin was discovered as a new endocrine hormone originating from fibrillin-1 cleavage that plays a crucial role in various metabolic-related diseases, such as obesity, nonalcoholic fatty liver disease (NAFLD), diabetes, polycystic ovary syndrome (PCOS), and cardiovascular diseases. The purpose of this review is to describe the recent advancements of asprosin. METHOD: Narrative review. RESULT: This comprehensive review explores its tissue-specific functions, focusing on white adipose tissue, liver, hypothalamus, testis, ovary, heart, pancreas, skeletal muscle, and kidney...
April 3, 2024: Journal of Endocrinological Investigation
https://read.qxmd.com/read/38565814/long-acting-exenatide-does-not-prevent-cognitive-decline-in-mild-cognitive-impairment-a-proof-of-concept-clinical-trial
#14
JOURNAL ARTICLE
A Dei Cas, M M Micheli, R Aldigeri, S Gardini, F Ferrari-Pellegrini, M Perini, G Messa, M Antonini, V Spigoni, G Cinquegrani, A Vazzana, V Moretti, P Caffarra, R C Bonadonna
PURPOSE: According to preclinical evidence, GLP-1 receptor may be an actionable target in neurodegenerative disorders, including Alzheimer's disease (AD). Previous clinical trials of GLP-1 receptor agonists were conducted in patients with early AD, yielding mixed results. The aim was to assess in a proof-of-concept study whether slow-release exenatide, a long-acting GLP-1 agonist, can benefit the cognitive performance of people with mild cognitive impairment (MCI). METHODS: Thirty-two (16 females) patients were randomized to either slow-release exenatide (n = 17; 2 mg s...
April 2, 2024: Journal of Endocrinological Investigation
https://read.qxmd.com/read/38556572/analysis-of-circulating-osteoclast-and-osteogenic-precursors-in-patients-with-gorham-stout-disease
#15
JOURNAL ARTICLE
M Rossi, S Terreri, G Battafarano, I Rana, P S Buonuomo, L Di Giuseppe, M D'Agostini, O Porzio, J Di Gregorio, Cristiana Cipriani, A Jenkner, M V Gonfiantini, A Bartuli, A Del Fattore
PURPOSE: Gorham-Stout disease is a very rare disorder characterized by progressive bone erosion and angiomatous proliferation; its etiopathogenesis is still unknown, and diagnosis is still performed by exclusion criteria. The alteration of bone remodeling activity has been reported in patients; in this study, we characterized circulating osteoclast and osteogenic precursors that could be important to better understand the osteolysis observed in patients. METHODS: Flow cytometry analysis of PBMC (Peripheral Blood Mononuclear Cells) was performed to characterize circulating osteoclast and osteogenic precursors in GSD patients (n = 9) compared to healthy donors (n = 55)...
April 1, 2024: Journal of Endocrinological Investigation
https://read.qxmd.com/read/38553585/thymic-hyperplasia-is-accurate-to-detect-new-onset-graves-hyperthyroidism-and-resolves-after-restoring-euthyroidism
#16
JOURNAL ARTICLE
L Scappaticcio, P Caruso, N Di Martino, P Ferrazzano, A Clemente, M I Maiorino, A Regginelli, G Docimo, P F Rambaldi, G Bellastella, P Trimboli, S Cappabianca, K Esposito
PURPOSE: Abnormal liver blood tests (ALBTs), neutropenia (NEU) and thymic hyperplasia (TH) are new features of Graves' disease (GD). Our objectives were: (a) to calculate the accuracy of TH in discriminating between Graves' and non-Graves' thyrotoxicosis, compared to ALBTs, NEU and Graves' orbitopathy (GO); (b) to explore the outcome of GD-associated TH and non-GD-associated TH. METHODS: We prospectively analyzed consecutive adult patients with newly diagnosed thyrotoxicosis from January 2018 to June 2023...
March 30, 2024: Journal of Endocrinological Investigation
https://read.qxmd.com/read/38546931/high-frequency-of-transient-congenital-hypothyroidism-among-infants-referred-for-suspected-congenital-hypothyroidism-from-the-turkish-national-screening-program-thyroxine-dose-may-guide-the-prediction-of-transients
#17
JOURNAL ARTICLE
Y Özer, A Anık, U Sayılı, U Tercan, R Deveci Sevim, S Güneş, M Buhur Pirimoğlu, S Elmaoğulları, I Dündar, D Ökdemir, Ö Besci, A Jalilova, D Çiçek, B Singin, Ş E Ulu, H Turan, S Albayrak, Z Kocabey Sütçü, B S Eklioğlu, E Eren, S Çetinkaya, Ş Savaş-Erdeve, I Esen, K Demir, Ş Darcan, N Hatipoğlu, M Parlak, F Dursun, Z Şıklar, M Berberoğlu, M Keskin, Z Orbak, B Tezel, E Yürüker, B Keskinkılıç, F Kara, E Erginöz, F Darendeliler, O Evliyaoğlu
PURPOSE: We aimed to determine the frequency of transient congenital hypothyroidism (TCH) in 17 participating centers in Türkiye, evaluate the etiological distribution in permanent congenital hypothyroidism (PCH) cases, and investigate the role of laboratory and clinical findings in predicting TCH. METHODS: This retrospective observational multicenter study included patients from 17 pediatric endocrinology centers identified by "National Newborn Screening Program" (NNSP) who were born in 2015 and followed for 6 years...
March 28, 2024: Journal of Endocrinological Investigation
https://read.qxmd.com/read/38539028/authorship-of-italian-medical-literature-on-neuroendocrine-neoplasms-any-gender-gap
#18
JOURNAL ARTICLE
R E Rossi, A La Salvia, R Modica, F Spada
PURPOSE: While males have dominated the physician lines over the last decades the recent female doctors' number increasing might progressively reduce this gender gap. This might be not fully true in the academic/research area. We aimed to analyze the gender distribution of first/senior Italian authors on neuroendocrine neoplasm papers published on peer reviewed journals. METHODS: Publications from January 2019 to September 2023 were reviewed; only papers with first and/or senior Italian authors were included...
March 28, 2024: Journal of Endocrinological Investigation
https://read.qxmd.com/read/38536658/development-of-diagnostic-algorithm-for-cushing-s-syndrome-a-tertiary-centre-experience
#19
JOURNAL ARTICLE
A Efthymiadis, H Loo, B Shine, T James, B Keevil, J W Tomlinson, A Pal, R Pofi
PURPOSE: No consensus exists as the gold standard for Cushing's Syndrome (CS) screening. This study aimed to evaluate the diagnostic accuracy and utility of late-night salivary cortisol (LNSC) and cortisone (LNSE), overnight dexamethasone suppression test (ODST), and urinary free cortisol (UFC) in developing a screening algorithm for CS. METHODS: A retrospective, single-centre analysis on 93 adult patients referred to the Oxford Centre for Diabetes, Endocrinology, and Metabolism for CS evaluation (2017-2022)...
March 27, 2024: Journal of Endocrinological Investigation
https://read.qxmd.com/read/38536657/increased-risk-of-erythrocytosis-in-men-with-type-2-diabetes-treated-with-combined-sodium-glucose-cotransporter-2-inhibitor-and-testosterone-replacement-therapy
#20
JOURNAL ARTICLE
A R Gosmanov, D E Gemoets, K A Schumacher
PURPOSE: In clinical trials, sodium-glucose cotransporter-2 inhibitors (SGLT-2i) and testosterone replacement therapy (TRT) were shown to stimulate red blood cell production. Little is known if combination therapy poses risk of erythrocytosis in real world clinical practice. METHODS: This was a retrospective nationwide cohort study of US Veterans with type 2 diabetes (T2D) and baseline hematocrit between 38 and 50% who were prescribed SGLT-2i and/or TRT between 3/2013 and 10/2022 and had adequate adherence based on the proportion of days covered > 80%...
March 27, 2024: Journal of Endocrinological Investigation
journal
journal
27431
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.